Relationship between hyperglycemia and outcome in children with severe traumatic brain injury

Rebecca L Smith1, John C Lin, P David Adelson

  • 1Department of Critical Care Medicine, Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, PA, USA. smithr3@upmc.edu

Insights

Hyperglycemia after the first 48 hours of severe traumatic brain injury in children is linked to worse outcomes. This suggests a connection between high blood sugar and injury severity, but further research is needed.

Area of Science:

  • Pediatric critical care
  • Neurotrauma research
  • Endocrinology

Background:

  • Severe traumatic brain injury (TBI) in children presents significant management challenges.
  • Glycemic control is a critical factor in patient outcomes following critical illness and injury.
  • The specific impact of hyperglycemia on pediatric TBI outcomes requires further elucidation.

Purpose of the Study:

  • To investigate the association between hyperglycemia and clinical outcomes in pediatric patients with severe traumatic brain injury.
  • To analyze the relationship between different levels of blood glucose and patient outcomes.

Main Methods:

  • Retrospective analysis of a prospectively collected Pediatric Neurotrauma Registry (1999-2004).
  • Inclusion criteria: children with severe TBI (Glasgow Coma Scale ≤ 8) and standard TBI protocol management.
  • Blood glucose levels were monitored, and outcomes were assessed, with analysis of early (0-48 hours) and late (49-168 hours) periods post-injury.

Main Results:

  • In the late period (49-168 hours post-injury), elevated mean serum glucose concentrations were significantly associated with unfavorable outcomes (p = .02).
  • Children experiencing severe hyperglycemia (blood glucose >200 mg/dL) in the late period showed a decreased incidence of good outcomes (33.3%) compared to those with normal or mild hyperglycemia.
  • This association between hyperglycemia and poor outcome persisted after adjusting for injury severity, age, and insulin use, although the link with severe hyperglycemia lost statistical significance after insulin adjustment.

Conclusions:

  • Hyperglycemia occurring beyond 48 hours after severe traumatic brain injury in children is associated with poorer outcomes.
  • Both mean glucose levels and episodic severe hyperglycemia correlate with adverse outcomes.
  • Prospective studies are necessary to determine if interventions targeting serum glucose concentration can improve outcomes in pediatric TBI.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...